|
US2020181565A1
|
|
Bacterial Growth on Non-Animal Derived Media
|
|
WO2020102791A1
|
|
Just-in-time bioprocess plant system
|
|
US2020030439A1
|
|
Mixtures of polysaccharide-protein pegylated compounds
|
|
US2020023050A1
|
|
Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
|
|
US2020009242A1
|
|
Heat Stable Vaccines
|
|
US2019374630A1
|
|
Virus-Like Particle Conjugates
|
|
WO2019032274A1
|
|
Double chamber device for point of use mixing
|
|
CN111295450A
|
|
Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration and multimodal chromatography
|
|
AU2018280272A1
|
|
Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
|
|
CN110730671A
|
|
Thermostable liquid rotavirus vaccine
|
|
US2017000882A1
|
|
Genetically detoxified pertussis vaccine that maintains intrinsic adjuvant activity
|
|
WO2017044932A1
|
|
Multivalent vlp conjugates
|
|
BR112018004400A2
|
|
stabilized vlp vaccine compositions
|
|
EP3283102A1
|
|
Bordetella pertussis immunogenic vaccine compositions
|
